CD9 and melanoma: These EVs were enriched with vesicular marker proteins (CD9, CD81 and Tsg101), tyrosinase, F4/80, alpha-smooth muscle actin and E-selectin, suggesting that melanoma cell-, macrophage-, fibroblast- and endothelial cell-derived EVs are present in the melanoma microenvironment.